INmune Bio gets US FDA nod for Phase II trial of Quellor, a sTNF inhibitor for COVID-19 treatment
Trial to evaluate the efficacy of Quellor to blunt the cytokine storm and decrease the catastrophic complications of COVID-19…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.